Company NeuroOne Medical Technologies Corporation Other OTC

Equities

NMTC

US64130M1009

Advanced Medical Equipment & Technology

Business Summary

Sales per Business

Sales per region

Managers

Members of the board

Share class

Shareholders

Company contact information

Sector

Sales per Business

Sector Medical Diagnostic & Testing Equipment

NeuroOne Medical Technologies Corporation is a medical technology company focused on improving surgical care options and outcomes for patients suffering from neurological disorders. The Company is focused on the development and commercialization of thin film electrode technology for continuous electroencephalogram (cEEG) and stereoelectrocencephalography (sEEG) recording, spinal cord stimulation, brain stimulation and ablation solutions for patients suffering from epilepsy, Parkinson's disease, dystonia, essential tremors, chronic pain due to failed back surgeries and other related neurological disorders. It may also pursue applications for other areas such as depression, mood disorders, pain, incontinence, high blood pressure and artificial intelligence. Its Evo cortical electrode technology records, monitors, and stimulates brain tissue on the surface of the brain. Its products include strip/grid, depth electrodes (sEEG Products) and electrode cable assembly products.

USD in Million	2022	Weight	2023	Weight	Delta
Strip/Grid Products, Stereoelectrocencephalography Products and Electrode Cable Assembly Products 57.3 %	0	8.1 %	2	57.3 %	+1,040.65%
Collaborations 42.7 %	2	91.9 %	1	42.7 %	-25.33%

USD in Million	2022	Weight	2023	Weight	Delta
United States 100.0 %	2	100.0 %	3	100.0 %	+60.73%

Managers	Title	Age	Since
Mark Christanson FOU	Founder	56	09-08-19
David Rosa CEO	Chief Executive Officer	59	17-07-19
Ronald McClurg DFI	Director of Finance/CFO	65	20-12-31
Christopher Volker COO	Chief Operating Officer	53	Nov. 09
Steven Mertens CTO	Chief Tech/Sci/R&D Officer	61	19-04-14
Chad Wilhelmy LAW	General Counsel	-	22-01-17
Hijaz Haris SAM	Sales & Marketing	-	21-04-26

Members of the board	Title	Age	Since
Paul Buckman CHM	Chairman	68	17-08-03
Jeffrey Mathiesen BRD	Director/Board Member	62	17-08-03
Edward Andrle BRD	Director/Board Member	66	20-02-17
David Rosa CEO	Chief Executive Officer	59	17-07-19

	Vote	Quantity	Free-Float	Company-owned shares	Total Float
Stock A	1	27,515,921	24,385,250 ( 88.62 %)	0	88.62 %

Name	Equities	%	Valuation
Manchester Management Co. LLC 8.491 %	2,364,052	8.491 %	2 M $
AWM Investment Co., Inc. 5.208 %	1,450,000	5.208 %	1 M $
Laurence Lytton 4.684 %	1,304,102	4.684 %	1 M $
Nantahala Capital Management LLC 4.306 %	1,198,912	4.306 %	959 130 $
David Rosa 4.151 %	1,155,661	4.151 %	924 529 $
Vanguard Group, Inc. (Subfiler) 3.302 %	919,321	3.302 %	735 457 $
Mark Christanson 1.058 %	294,692	1.058 %	235 754 $
Ronald McClurg 0.8768 %	244,117	0.8768 %	195 294 $
Geode Capital Management LLC 0.7972 %	221,949	0.7972 %	177 559 $
Mayo Medical Ventures 0.6528 %	181,754	0.6528 %	145 403 $

NeuroOne Medical Technologies Corp.

7599 Anagram Drive

55344, Eden Prairie

http://www.n1mtc.com

address NeuroOne Medical Technologies Corporation(NMTC)

Healthcare

Healthcare Services

Healthcare Equipment & Supplies

Advanced Medical Equipment & Technology

Medical Diagnostic & Testing Equipment

	1st Jan change	Capi.
SARTORIUS AG	-27.91%	16.33B
QUIDELORTHO CORPORATION	-56.07%	2.17B
INNER MONGOLIA FURUI MEDICAL SCIENCE CO., LTD.	+19.09%	1.88B
SHANGHAI MICROPORT EP MEDTECH CO., LTD.	-12.63%	1.45B
BIOTAGE AB	+29.99%	1.32B
REVENIO GROUP OYJ	+8.32%	853M
SHANGHAI AOHUA PHOTOELECTRICITY ENDOSCOPE CO., LTD.	-30.60%	799M
CONTEC MEDICAL SYSTEMS CO.,LTD	-36.50%	726M
CELLAVISION AB	+29.48%	622M

Medical Diagnostic & Testing Equipment